CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
EASYGEN aims to democratize access to Chimeric Antigen Receptor T-cell therapy for cancer treatment by developing an automated, modular platform for on-site manufacturing. This innovation seeks to reduce costs and improve patient outcomes in standard hospital settings.
More than 20 million new patients world-wide are diagnosed with cancer every year, and prediction for 2050 foresee over 35 million cancer cases, reflecting the population ageing and growth with a tremendous burden on the health care system. A global WHO survey with 115 participating countries has shown, that only 39% can cover basic cancer care management, financed as core health service.
This reveals significant global inequities between high GNP and low- and middle-income countries, which is a…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Helios Klinikum Berlin-Buch GmbH
Germany, Berlin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
PHILIPS ELECTRONICS NEDERLAND BV
Netherlands, Eindhoven
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY GMBH
Germany, Freiburg
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Ireland, Dublin
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
